Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Deferred PrEP in Pregnant and Lactating Women
NCT03227731Phase 3Completed
- Sponsor
- University of KwaZulu-Natal
- Start
- Sep 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of KwaZulu-Natal. Started Sep 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03227731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227731.